ORPHA:280847
Congenital pulmonary airway malformation type 3
Also known as: CCAM type 3 · CPAM type 3 · Congenital cystic adenomatoid malformation of the lung type 3 · Congenital cystic adenomatous malformation of the lung type 3 · Congenital cystic disease of the lung type 3
Publications
22
33.9th percentile
Trials
0
Interventional, condition-specific
Researchers
109
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A rare subtype of pulmonary airway characterized by a multicystic mass of non-functioning lung tissue consisting of numerous microcysts of less than 0.5 cm in diameter. The lesions have intracystic communications, can be connected to the tracheobronchial tree, and are usually unilateral, involving an entire lobe. The condition may be associated with polyhydramnios, fetal hydrops, and stillbirth, or present with severe respiratory distress in the period.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0017251
- UMLS:C5437762
Additional Mondo synonyms (3)
congenital cystic adenomatoid malformation of the lung type 3 · congenital cystic adenomatous malformation of the lung type 3 · congenital cystic disease of the lung type 3
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
22 matched papers (16 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPartial
None under the specific name; 2 for broader category congenital pulmonary airway malformation
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
22
22 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
22 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
16 in the last 10 years · high confidence · 33.9th percentile (publications denominator)
Phrase hits: 22 · MeSH hits: 0
Who's working on it?
109
Distinct author names in 22 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Dehner LP2 papers · 2026
Lauren V. Ackerman Laboratory of Surgical Pathology, Department of Pathology and Immunology, Washington University Medical Center, St. Louis, MO
Papers in Europe PMC - 02Abbasoglu L1 paper · 2012Papers in Europe PMC
- 03Abeer I1 paper · 2023
Department of Pathology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, J and K, India.
Papers in Europe PMC - 04Abu Ghanimeh M1 paper · 2016
Department of Internal medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA.
Papers in Europe PMC - 05Abu Omar M1 paper · 2016
University of Missouri-Kansas City, Pulmonary/Critical Care, Kansas City, Missouri, USA.
Papers in Europe PMC - 06Abur Ü1 paper · 2025
Ondokuz Mayis University, Faculty of Medicine, Department of Medical Genetics - Samsun, Turkey.
Papers in Europe PMC - 07Agrawal M1 paper · 2024
Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
Papers in Europe PMC - 08Ahuja S1 paper · 2024
Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India. Electronic address: sanaahuja11@yahoo.com.
Papers in Europe PMC - 09Aksoy Ozcan U1 paper · 2012
Department of Radiology, School of Medicine, Acibadem University, Istanbul, Turkey.
Papers in Europe PMC - 10Altun E1 paper · 2012Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 2 trials are registered for congenital pulmonary airway malformation, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 27 July 2026
No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.
high confidence · 36.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
2 interventional trials matched congenital pulmonary airway malformation, the broader category — listed below. Those studies are not counted in the condition-specific total.
Broader category: congenital pulmonary airway malformation
2
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT05701514·RECRUITING·The COllaborative Neonatal Network for the First CPAM Trial
Conditions: Congenital Pulmonary Airway Malformation·Matched via name phrase
- NCT06302985·RECRUITING·Atomized Inhalation ICG for Treatment of Congenital Lung Malformations
Conditions: Pulmonary Sequestration · Congenital Pulmonary Airway Malformation · Indocyanine Green · Thoracoscopic Surgery·Matched via name phrase
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Congenital pulmonary airway malformation type 3" OR "CCAM type 3" OR "CPAM type 3" OR "Congenital cystic adenomatoid malformation of the lung type 3" OR "Congenital cystic adenomatoid malformation of lung type 3" OR "Congenital cystic adenomatous malformation of the lung type 3" OR "Congenital cystic adenomatous malformation of lung type 3" OR "Congenital cystic disease of the lung type 3" OR "Congenital cystic disease of lung type 3"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Congenital pulmonary airway malformation type 3" OR "CCAM type 3" OR "CPAM type 3" OR "Congenital cystic adenomatoid malformation of the lung type 3" OR "Congenital cystic adenomatoid malformation of lung type 3" OR "Congenital cystic adenomatous malformation of the lung type 3" OR "Congenital cystic adenomatous malformation of lung type 3" OR "Congenital cystic disease of the lung type 3" OR "Congenital cystic disease of lung type 3"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"congenital pulmonary airway malformation"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T11:58:28.998Z